As it was observed that NLGP mediated prevention of tumor recurrence after surgical removal of sarcoma is dependent on CD8+ T cells, further the status of different regulatory cells (TAMs, Tregs, DC2, MDSCs) was observed, which may play a rate limiting role on CD8+ T cell functions. This evidence concerns the gene CD8A and sarcoma.